Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Aug '25 Aug 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Market Capitalization	5,630	4,973	4,614	3,928	3,366	-	Upgrade
Market Cap Growth	15.60%	7.79%	17.47%	16.69%	-	-	Upgrade
Enterprise Value	5,761	5,043	4,681	4,134	3,654	-	Upgrade
PE Ratio	8.65	7.23	6.93	5.58	6.16	-	Upgrade
PS Ratio	4.77	4.14	4.00	3.59	3.01	-	Upgrade
PB Ratio	1.08	1.00	1.00	0.96	0.82	-	Upgrade
P/OCF Ratio	8.04	7.25	7.30	7.01	5.88	-	Upgrade
EV/Sales Ratio	4.71	4.20	4.06	3.78	3.27	-	Upgrade
EV/EBIT Ratio	6.30	5.34	5.18	4.34	4.88	-	Upgrade
Debt / Equity Ratio	0.14	0.15	0.16	0.19	0.19	0.20	Upgrade
Debt / EBITDA Ratio	0.81	0.79	0.84	0.79	1.01	1.53	Upgrade
Quick Ratio	1.01	1.00	4.15	2.64	1.91	1.63	Upgrade
Current Ratio	1.09	1.08	4.40	2.81	2.03	1.72	Upgrade
Asset Turnover	0.19	0.19	0.19	0.19	0.19	0.22	Upgrade
Return on Equity (ROE)	13.47%	14.29%	15.24%	17.16%	13.69%	9.61%	Upgrade
Return on Assets (ROA)	8.71%	9.29%	9.49%	10.30%	8.13%	6.04%	Upgrade
Return on Capital (ROIC)	9.91%	10.60%	11.01%	12.26%	9.85%	7.24%	Upgrade
Earnings Yield	12.02%	13.84%	14.42%	17.93%	16.24%	-	Upgrade
Earnings Yield	12.02%	13.84%	14.42%	17.93%	16.24%	-	Upgrade
Dividend Yield	2.23%	2.23%	2.22%	1.89%	-	-	Upgrade
Payout Ratio	17.34%	16.24%	32.00%	35.61%	36.64%	118.07%	Upgrade
Buyback Yield / Dilution	3.98%	2.65%	0.89%	-0.26%	-0.02%	-	Upgrade
Total Shareholder Return	6.18%	4.89%	3.11%	1.64%	-0.02%	-	Upgrade

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.

SEC Filings: 10-K · 10-Q